Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0042-1757955
Prevalence of Screening for Diabetes Mellitus in Patients Previously Diagnosed with Gestational Diabetes: Factors Related to its Performance
Prevalência do rastreamento de diabetes mellitus em pacientes diagnosticadas previamente com diabetes gestacional: fatores relacionados à sua realização![](https://www.thieme-connect.de/media/10.1055-s-00030576/202211/lookinside/thumbnails/10-1055-s-0042-1757955_220064-1.jpg)
Abstract
Objective To determine how many patients underwent screening for diabetes mellitus (DM) in the puerperium after a diagnosis of gestational DM (GDM) and which factors were related to its performance.
Methods The present is a prospective cohort study with 175 women with a diagnosis of GDM. Sociodemographic and clinico-obstetric data were collected through a questionnaire and a screening test for DM was requested six weeks postpartum. After ten weeks, the researchers contacted the patients by telephone with questions about the performance of the screening. The categorical variables were expressed as absolute and relative frequencies. The measure of association was the relative risk with a 95% confidence interval (95%CI), and values of p ≤ 0.05 were considered statistically significant and tested through logistic regression.
Results The survey was completed by 159 patients, 32 (20.1%) of whom underwent puerperal screening. The mean age of the sample was of 30.7 years, and most patients were white (57.9%), married (56.6%), and had had 8 or more years of schooling (72.3%). About 22.6% of the patients used medications to treat GDM, 30.8% had other comorbidities, and 76.7% attended the postnatal appointment. Attendance at the postpartum appointment, the use of medication, and the presence of comorbidities showed an association with the performance of the oral glucose tolerance test in the puerperium.
Conclusion The prevalence of screening for DM six weeks postpartum is low in women previously diagnosed with GDM. Patients who attended the postpartum consultation, used medications to treat GDM, and had comorbidities were the most adherent to the puerperal screening. We need strategies to increase the rate of performance of this exam.
Resumo
Objetivo Determinar quantas pacientes realizaram o rastreamento puerperal para diabetes mellitus (DM) após diagnóstico de DM gestacional (DMG) e quais fatores estão relacionados com a sua realização.
Métodos Trata-se de um estudo com uma coorte prospectiva de 175 puérperas com diagnóstico de DMG. Informações sociodemográficas e clinico-obstétricas foram coletadas por meio de questionário, e solicitou-se a realização do rastreamento para DM às seis semanas de pós-parto. Após dez semanas, os pesquisadores contataram as pacientes por telefone com questões sobre a realização do rastreamento. As variáveis categóricas foram expressas em termos de frequências absoluta e relativa. A medida de associação foi o risco relativo com intervalo de confiança de 95% (IC95%), e valores de p ≤ 0,05 foram considerados estatisticamente significativos e testados por regressão logística.
Resultados A pesquisa foi concluída por 159 pacientes, 32 (20,1%) das quais fizeram o rastreamento puerperal. A idade média da amostra foi de 30,7 anos, e a maioria das pacientes eram brancas (57,9%), casadas (56,6%) e tinham 8 ou mais anos de escolaridade (72,3%). Cerca de 22,6% utilizaram medicações para tratamento da DMG, 30,8% eram portadoras de outras comorbidades, e 76,7% compareceram na consulta pós-natal. O comparecimento na consulta pós-parto, a utilização de medicamentos e a presença de comorbidades demonstraram associação com a realização do teste oral de tolerância à glicose no puerpério.
Conclusão O rastreamento de DM após seis semanas de puerpério é baixo em mulheres com diagnóstico prévio de DMG. Pacientes que compareceram na consulta pós-parto, utilizaram medicações para tratamento da DMG, e eram portadoras de comorbidades foram as mais aderentes à realização do rastreamento puerperal. Necessitamos de estratégias para aumentar a abrangência da realização desse exame.
Palavras-chave
diabetes gestacional - programas de rastreamento - período pós-parto - diabetes mellitusPublication History
Received: 21 February 2022
Accepted: 10 August 2022
Article published online:
29 December 2022
© 2022. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels: IDF; 2019
- 2 Organização Pan-Americana da Saúde, Ministério da Saúde, Federação Brasileira das Associações de Ginecologia e Obstetrícia, Sociedade Brasileira de Diabetes. Rastreamento e diagnóstico de diabetes mellitus gestacional no Brasil. Brasília (DF): OPAS; 2016
- 3 Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P. et al; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33 (03) 676-682 DOI: 10.2337/dc09-1848.
- 4 Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373 (9677): 1773-1779 DOI: 10.1016/S0140-6736(09)60731-5.
- 5 Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ 2020; 369: m1361 DOI: 10.1136/bmj.m1361.
- 6 Miao Z, Wu H, Ren L, Ren L, Bu N, Jiang L, Yang H. et al. Long-Term Postpartum Outcomes of Insulin Resistance and β-cell Function in Women with Previous Gestational Diabetes Mellitus. Int J Endocrinol 2020; 2020: 7417356 DOI: 10.1155/2020/7417356.
- 7 American College of Obstetricians and Gynecologists. Practice Bulletin No. 180: gestational diabetes mellitus. Obstet Gynecol 2017; 130 (01) e17-e37 DOI: 10.1097/AOG.0000000000002159.
- 8 Guo J, Chen JL, Whittemore R, Whitaker E. Postpartum lifestyle interventions to prevent type 2 diabetes among women with history of gestational diabetes: a systematic review of randomized clinical trials. J Womens Health (Larchmt) 2016; 25 (01) 38-49 DOI: 10.1089/jwh.2015.5262.
- 9 Miao ZR, Wu HH, Zhang YZ, Sun WJ, Lu DF, Yang HX. et al. Evaluation of the gestational diabetes mellitus diagnostic criteria recommended by the international association of diabetes and pregnancy study group for long-term maternal postpartum outcomes in mainland China. Medicine (Baltimore) 2020; 99 (08) e19242 DOI: 10.1097/MD.0000000000019242.
- 10 Tobias DK, Stuart JJ, Li S, Chavarro J, Rimm EB, Rich-Edwards J. et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US Women. JAMA Intern Med 2017; 177 (12) 1735-1742 DOI: 10.1001/jamainternmed.2017.2790.
- 11 Rotem R, Salem-Yaniv S, Sandler-Rahat H, Yohay D, Shanny S, Yahav L. et al. Adherence to postpartum diabetes mellitus screening, do associated pregnancy complications make a difference?. Diabetes Res Clin Pract 2020; 159: 107972 DOI: 10.1016/j.diabres.2019.107972.
- 12 Stasenko M, Liddell J, Cheng YW, Sparks TN, Killion M, Caughey AB. Patient counseling increases postpartum follow-up in women with gestational diabetes mellitus. Am J Obstet Gynecol 2011; 204 (06) 522.e1-522.e6 DOI: 10.1016/j.ajog.2011.01.057.
- 13 Tang Y, Guo J, Long Q, Yang J, Luo J, Yang S. et al. Factors influencing postpartum blood glucose screening among women with prior gestational diabetes mellitus in a rural community. J Adv Nurs 2020; 76 (08) 2151-2160 DOI: 10.1111/jan.14440.
- 14 de Gennaro G, Bianchi C, Aragona M, Battini L, Baronti W, Brocchi A. et al. Postpartum screening for type 2 diabetes mellitus in women with gestational diabetes: Is it really performed?. Diabetes Res Clin Pract 2020; 166: 108309 DOI: 10.1016/j.diabres.2020.108309.
- 15 Ortiz FM, Jimenez EY, Boursaw B, Huttlinger K. Postpartum care for women with gestational diabetes. MCN Am J Matern Child Nurs 2016; 41 (02) 116-122 DOI: 10.1097/NMC.0000000000000215.
- 16 Cabizuca CA, Rocha PS, Marques JV, Costa TF, Santos AS, Schröder AL. et al. Postpartum follow up of gestational diabetes in a Tertiary Care Center. Diabetol Metab Syndr 2018; 10: 2 DOI: 10.1186/s13098-017-0303-4.
- 17 Napoli A, Sciacca L, Pintaudi B, Tumminia A, Dalfra MG, Festa C. et al; STRONG Study Collaborators and the AMD-SID Diabetes and Pregnancy Study Group. Screening of postpartum diabetes in women with gestational diabetes: high-risk subgroups and areas for improvements-the STRONG observational study. Acta Diabetol 2021; 58 (09) 1187-1197 DOI: 10.1007/s00592-021-01707-9.
- 18 Farid H, Blake R, Hacker MR, Erlinger AL, Modest AM. Strategies to improve postpartum glucose screening rates are needed. J Obstet Gynaecol Res 2021; 47 (08) 2641-2645 DOI: 10.1111/jog.14868.
- 19 Paul JC, Fitzpatrick JJ. Postpartum glucose screening among women with gestational diabetes. Appl Nurs Res 2020; 56: 151341 DOI: 10.1016/j.apnr.2020.151341.
- 20 Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E. et al; Diabetes Prevention Program Research Group. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab 2015; 100 (04) 1646-1653 DOI: 10.1210/jc.2014-3761.
- 21 Lawrence JM, Black MH, Hsu JW, Chen W, Sacks DA. Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus. Diabetes Care 2010; 33 (03) 569-576 DOI: 10.2337/dc09-2095.
- 22 Rosenbloom JI, Blanchard MH. Compliance with postpartum diabetes screening recommendations for patients with gestational diabetes. J Womens Health (Larchmt) 2018; 27 (04) 498-502 DOI: 10.1089/jwh.2017.6477.
- 23 Jones KE, Yan Y, Colditz GA, Herrick CJ. Prenatal counseling on type 2 diabetes risk, exercise, and nutrition affects the likelihood of postpartum diabetes screening after gestational diabetes. J Perinatol 2018; 38 (04) 315-323 DOI: 10.1038/s41372-017-0035-1.
- 24 Butalia S, Donovan L, Savu A, Johnson J, Edwards A, Kaul P. Postpartum diabetes testing rates after gestational diabetes mellitus in canadian women: a population-based study. Can J Diabetes 2017; 41 (06) 613-620 DOI: 10.1016/j.jcjd.2016.12.013.
- 25 Liu ZY, Zhao JJ, Gao LL, Wang AY. Glucose screening within six months postpartum among Chinese mothers with a history of gestational diabetes mellitus: a prospective cohort study. BMC Pregnancy Childbirth 2019; 19 (01) 134 DOI: 10.1186/s12884-019-2276-9.
- 26 Quaresima P, Visconti F, Chiefari E, Puccio L, Foti DP, Venturella R. et al. Barriers to postpartum glucose intolerance screening in an italian population. Int J Environ Res Public Health 2018; 15 (12) 2853 DOI: 10.3390/ijerph15122853.